Journal: Advanced Science
Article Title: Sleep Deprivation Triggers the Excessive Activation of Ovarian Primordial Follicles via β2 Adrenergic Receptor Signaling
doi: 10.1002/advs.202402393
Figure Lengend Snippet: Activated ADRB2 upregulates KITL via the cAMP/PKA pathway. A) After treating mice with the ADRB2 agonist CLEN, Western blot analysis revealed high expression of KIT/KITL in ovarian tissue (KIT: CON n = 3, CLEN n = 4), (KITL: CON n = 5, CLEN n = 6). Statistical methods: KIT: Independent Samples Test; KITL: Mann‐Whitney Test. B) Similarly, after treatment with another ADRB2 agonist SAL, Western blot analysis showed high expression of KIT/ KITL in ovarian tissue (CON n = 3, SAL n = 3). Statistical methods: KIT: Independent Samples Test; KITL: Mann‐Whitney Test. C) Stimulation of the human granulosa cell line KGN with CLEN and SAL at a concentration of 1 and 100 µ m , respectively, resulted in a significant upregulation of KITL mRNA expression (CON n = 3, CLEN n = 3) (CON n = 3, SAL n = 3). Statistical method: Independent Samples Test. D,E) Following treatment with CLEN and SAL, Western blot analysis revealed a significant increase in KITL protein levels in KGN cells (CON n = 5, CLEN n = 4) (CON n = 4, SAL n = 4). Statistical method: Independent Samples Test. F) After treatment with CLEN and SAL, KGN cells were collected and subjected to cAMP ELISA testing, which showed a significant increase in cellular cAMP content compared to control cells (CON n = 4, CLEN n = 4; SAL n = 4). Statistical method: One‐way ANOVA with LSD Test. G,H) Following treatment with CLEN and SAL, Western blot analysis showed a significant upregulation of p‐PKA levels in KGN cells (CON n = 3, CLEN n = 3) (CON n = 4, SAL n = 4). Statistical method: Independent Samples Test. I) Correlation analysis of the protein levels of KITL and p‐PKA in KGN cells revealed a strong correlation between the expression levels of these two proteins, with a Pearson correlation of 0.925 ( n = 8, p = 0.001**). J) After treating KGN cells with 20 µ m of cAMP, the expression level of KITL significantly increased (CON n = 4, cAMP n = 4). Statistical method: Mann‐Whitney Test. K) Treatment of KGN cells with 10 n m concentration of the PKA activator BC resulted in a significant upregulation of KITL levels (CON n = 4, BC n = 5). Statistical method: Independent Samples Test. L,M) Treatment of KGN with the PKA antagonists STA and H89 in a 100 n m concentration led to a significant downregulation of KITL levels (CON n = 5, STA n = 4) (CON n = 5, H89 n = 4). Statistical method: Independent Samples Test. Data are presented as mean with SEM. In all panels, * p < 0.05, ** p < 0.01, and *** p < 0.001. CON, control; CLEN, Clenbuterol; SAL, Salbutamol; BC, Bucladesine sodium; STA, Staurosporine; H89, H‐89 dihydrochloride; KITL, KIT ligand.
Article Snippet: The ADRB2 antagonist ICI (MCE, HY‐13951), dissolved in DMSO, was administered via daily intraperitoneal injections (5 mg kg −1 ) for 6 days.
Techniques: Western Blot, Expressing, MANN-WHITNEY, Concentration Assay, Enzyme-linked Immunosorbent Assay, Control